Bafilomycin C1

Overview

Bafilomycin C1 is a macrolide antibiotic isolated from Streptomyces sp . Bafilomycin C1 is a potent, specific and reversible inhibitor of vacuolar-type H + -ATPases (V-ATPases) . Bafilomycin C1 inhibits growth of gram-positive bacteria and fungi . Bafilomycin C1 induces cell apoptosis and can be used for the study of hepatocellular carcinoma (HCC).

Application

Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Fungal | Products > Signaling Pathways > Na+/K+ ATPase | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Antibiotic

Product Information

• Catalog No.: HY-130173
• CAS No.: 88979-61-7
• Molecular Formula: C39H60O12
• Molecular Weight: 720.89
• Purity: 99.9%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source